Rubric Capital Management (New York)’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$635K Sell
2025
Q1
$4.24M Hold
2024
Q4
$7.26M Sell
2024
Q3
$10.8M Hold
2024
Q2
$18M Hold
2024
Q1
$24.9M Buy
2023
Q4
$1.32M Buy
2020
Q2
Sell
2020
Q1
$25.7M Sell
2019
Q4
$38.3M Buy
2019
Q3
$41.3M Buy
2019
Q2
$15.5M Sell
2019
Q1
$36M Sell
2018
Q4
$27.6M Buy
2018
Q3
$10.4M Buy
2018
Q2
$4.78M Sell
2018
Q1
$5.12M Buy